NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Timothy Werth, a tech editor at Mashable, joins “CBS News 24/7” to discuss the best gadgets of 2025.Read More